Daptomycin Resistance in Clinical MRSA Strains Is Associated with a High Biological Fitness Cost
出版年份 2017 全文链接
标题
Daptomycin Resistance in Clinical MRSA Strains Is Associated with a High Biological Fitness Cost
作者
关键词
-
出版物
Frontiers in Microbiology
Volume 8, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2017-12-05
DOI
10.3389/fmicb.2017.02303
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Down-regulation of the two-component system and cell-wall biosynthesis-related genes was associated with the reversion to daptomycin susceptibility in daptomycin non-susceptible methicillin-resistant Staphylococcus aureus
- (2017) Y. Iwata et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- In vivo development of daptomycin resistance in vancomycin-susceptible methicillin-resistant Staphylococcus aureus severe infections previously treated with glycopeptides
- (2016) A. Capone et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Improvements to PATRIC, the all-bacterial Bioinformatics Database and Analysis Resource Center
- (2016) Alice R. Wattam et al. NUCLEIC ACIDS RESEARCH
- Mechanisms of drug resistance: daptomycin resistance
- (2015) Truc T. Tran et al. Annals of the New York Academy of Sciences
- Stepwise Decrease in Daptomycin Susceptibility in Clinical Staphylococcus aureus Isolates Associated with an Initial Mutation inrpoBand a Compensatory Inactivation of theclpXGene
- (2015) Kristoffer T. Bæk et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Frequency and Distribution of Single-Nucleotide Polymorphisms withinmprFin Methicillin-Resistant Staphylococcus aureus Clinical Isolates and Their Role in Cross-Resistance to Daptomycin and Host Defense Antimicrobial Peptides
- (2015) Arnold S. Bayer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multiple pathways of cross-resistance to glycopeptides and daptomycin in persistent MRSA bacteraemia
- (2015) Chih-Jung Chen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Risk factors associated with the onset of daptomycin non-susceptibility in Staphylococcus aureus infections in critically ill patients
- (2014) Matteo Bassetti et al. INTENSIVE CARE MEDICINE
- Phenotypic and Genotypic Characterization of Daptomycin-Resistant Methicillin-Resistant Staphylococcus aureus Strains: Relative Roles of mprF and dlt Operons
- (2014) Nagendra N. Mishra et al. PLoS One
- Causal Role of Single Nucleotide Polymorphisms within themprFGene of Staphylococcus aureus in Daptomycin Resistance
- (2013) Soo-Jin Yang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Methicillin-Resistant Staphylococcus aureus: An Evolving Pathogen
- (2013) M. E. Stryjewski et al. CLINICAL INFECTIOUS DISEASES
- Mechanisms of daptomycin resistance inStaphylococcus aureus: role of the cell membrane and cell wall
- (2012) Arnold S. Bayer et al. Annals of the New York Academy of Sciences
- Contribution of Selected Gene Mutations to Resistance in Clinical Isolates of Vancomycin-Intermediate Staphylococcus aureus
- (2012) Cory Hafer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- snpTree - a web-server to identify and construct SNP trees from whole genome sequence data
- (2012) Pimlapas Leekitcharoenphon et al. BMC GENOMICS
- Whole Genome Characterization of the Mechanisms of Daptomycin Resistance in Clinical and Laboratory Derived Isolates of Staphylococcus aureus
- (2012) Anton Y. Peleg et al. PLoS One
- VraSR Two-Component Regulatory System Contributes tomprF-Mediated Decreased Susceptibility to Daptomycin inIn Vivo-Selected Clinical Strains of Methicillin-Resistant Staphylococcus aureus
- (2011) Shrenik Mehta et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children: Executive Summary
- (2011) Catherine Liu et al. CLINICAL INFECTIOUS DISEASES
- An RpoB Mutation Confers Dual Heteroresistance to Daptomycin and Vancomycin in Staphylococcus aureus
- (2010) L. Cui et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications
- (2010) B. P. Howden et al. CLINICAL MICROBIOLOGY REVIEWS
- Emergence of daptomycin resistance following vancomycin-unresponsive Staphylococcus aureus bacteraemia in a daptomycin-naïve patient—a review of the literature
- (2010) S. J. van Hal et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Antibiotic resistance and its cost: is it possible to reverse resistance?
- (2010) Dan I. Andersson et al. NATURE REVIEWS MICROBIOLOGY
- The European Nucleotide Archive
- (2010) R. Leinonen et al. NUCLEIC ACIDS RESEARCH
- Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: facts and assumptions
- (2009) Pamela A Moise et al. LANCET INFECTIOUS DISEASES
- The Bacterial Defensin Resistance Protein MprF Consists of Separable Domains for Lipid Lysinylation and Antimicrobial Peptide Repulsion
- (2009) Christoph M. Ernst et al. PLoS Pathogens
- Spontaneous Deletion of the Methicillin Resistance Determinant, mecA, Partially Compensates for the Fitness Cost Associated with High-Level Vancomycin Resistance in Staphylococcus aureus
- (2008) M. J. Noto et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started